Saint Jude Medical Center — Fullerton, California

Public research footprint of Saint Jude Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IIIA Lung Non-Small Cell Cancer AJCC v7 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Lung Non-Small Cell Cancer AJCC v7 · Recurrent Malignant Uterine Corpus Neoplasm

Recently updated registry entries

NCT02954874 — Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast… (Active Not Recruiting)
NCT02152982 — Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed… (Active Not Recruiting)
NCT01274338 — Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Saint Jude Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.